Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion
Clinical trial NCT03725085 · COMPLETED
Trial details
- NCT number
- NCT03725085
- Sponsor
- Reckitt Benckiser LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-24
- Primary completion
- 2015-10-16
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.